Nov 26 (Reuters) - Intelligent Bio Solutions Inc INBS.O:
INTELLIGENT BIO SOLUTIONS ACHIEVES 94.1% ACCURACY IN METHOD COMPARISON STUDY, FOLLOWING POSITIVE PK STUDY RESULTS
INTELLIGENT BIO SOLUTIONS: FINGERPRINTING DRUG SCREENING SYSTEM ON PATH TO FDA 510$(K)$ SUBMISSION, EXPECTED IN FOURTH CALENDAR QUARTER OF 2024
Source text: ID:nGNX24nyQD
Further company coverage: INBS.O
((Reuters.Briefs@thomsonreuters.com;))